Tirzepatide Pen
GIP/GLP-1 Receptor Dual Agonist
Tirzepatide Pen (GIP/GLP-1 Receptor Dual Agonist) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Pre-filled, pre-reconstituted Tirzepatide auto-injector pen. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.
Scientific name
GIP/GLP-1 Receptor Dual Agonist
Molecular weight
4813.5 g/mol
Purity
98.7%
Vial size
10mg
DOCUMENTED RESEARCH AREAS
- ▸Pre-filled, pre-reconstituted pen — no mixing required and consistent metered dosing
- ▸Dual GIP and GLP-1 receptor activation combining two incretin pathways in one molecule
- ▸Enhances glucose-dependent insulin secretion and improves insulin sensitivity
- ▸Substantial body weight reduction demonstrated in clinical research models
- ▸Slows gastric emptying and modulates central satiety signalling
- ▸Improves glycaemic control beyond GLP-1 mono-agonist comparators
- ▸Studied for lipid metabolism and hepatic fat reduction in metabolic research
CITED LITERATURE (PUBMED)
All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human or animal consumption.